- Malaysia
- /
- Healthcare Services
- /
- KLSE:ALPHA
We Think That There Are Some Issues For Alpha IVF Group Berhad (KLSE:ALPHA) Beyond Its Promising Earnings
The recent earnings posted by Alpha IVF Group Berhad (KLSE:ALPHA) were solid, but the stock didn't move as much as we expected. However the statutory profit number doesn't tell the whole story, and we have found some factors which might be of concern to shareholders.
See our latest analysis for Alpha IVF Group Berhad
Zooming In On Alpha IVF Group Berhad's Earnings
One key financial ratio used to measure how well a company converts its profit to free cash flow (FCF) is the accrual ratio. The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.
As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.
Alpha IVF Group Berhad has an accrual ratio of 0.42 for the year to November 2024. That means it didn't generate anywhere near enough free cash flow to match its profit. Statistically speaking, that's a real negative for future earnings. Indeed, in the last twelve months it reported free cash flow of RM47m, which is significantly less than its profit of RM57.1m. Alpha IVF Group Berhad's free cash flow actually declined over the last year, but it may bounce back next year, since free cash flow is often more volatile than accounting profits.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Alpha IVF Group Berhad's Profit Performance
As we discussed above, we think Alpha IVF Group Berhad's earnings were not supported by free cash flow, which might concern some investors. As a result, we think it may well be the case that Alpha IVF Group Berhad's underlying earnings power is lower than its statutory profit. But at least holders can take some solace from the 23% EPS growth in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. When we did our research, we found 2 warning signs for Alpha IVF Group Berhad (1 is potentially serious!) that we believe deserve your full attention.
Today we've zoomed in on a single data point to better understand the nature of Alpha IVF Group Berhad's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KLSE:ALPHA
Alpha IVF Group Berhad
Operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia and Singapore.
Flawless balance sheet with high growth potential.